US Corporate Board Director Changes SEC Filings — December 17, 2025

18-12-2025

UNITY BANCORP INC /NJ/ filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, individual name, appointment/resignation status, reason, or quantitative data such as transaction values, share counts, or financial metrics are provided in the filing summary. This appears to be a routine disclosure with limited information available for analysis.

• ·Item 5.02: Officer change event disclosed, but key details (position, name, reason) NOT_DISCLOSED
• ·Filed on 2025-12-18; AccNo: 0000920427-25-000085
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·Sector not specified

18-12-2025

Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, but no specific details on positions, reasons, or individuals are provided in the summary. Quantitative data such as transaction values, share counts, or percentages are NOT_DISCLOSED. Analysis is limited by lack of filing content, resulting in neutral implications.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details (position, appointment/resignation, reason) NOT_DISCLOSED.
• ·Filed within SEC 8-K timeline (within 4 business days), compliant with disclosure requirements.
• ·No board meeting outcomes, financial metrics, or governance impacts specified.

18-12-2025

NexMetals Mining Corp. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with other events (Item 8.01) and exhibits (Item 9.01). No specific details on the officer position, appointment/departure, reasons, or quantitative data are provided in the summary. This is a routine SEC disclosure with limited actionable information.

• ·Item 5.02 triggered: Indicates departure, election, or appointment of directors/officers, but specifics NOT_DISCLOSED.
• ·Items 8.01 and 9.01 included: Other events and exhibits mentioned, details NOT_DISCLOSED.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): ALL NOT_DISCLOSED.

18-12-2025

Northpointe Bancshares Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with Item 9.01 listing exhibits. No specific details on positions, individuals, reasons, or quantitative data provided in the summary. Analysis limited to filing structure; all key facts NOT_DISCLOSED.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangements
• ·Item 9.01 references financial statements and exhibits (Size: 174 KB)
• ·No names, positions, reasons, or numerical data explicitly stated

18-12-2025

Methode Electronics Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but specific details on position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing metadata; no substantive facts on leadership impact available.

• ·Item 5.02 disclosure signals officer change (departure, election, appointment, or compensatory arrangement), but key details NOT_DISCLOSED.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Sector not specified; critical information on position affected, timing, and reasons missing, limiting analysis quality.

18-12-2025

Cartesian Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change (Item 5.02), amendment to Code of Ethics (Item 5.05), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on positions, reasons, or individuals provided. Quantitative data NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors, but key position, type, and reason NOT_DISCLOSED.
• ·Item 5.05 reports Code of Ethics amendment or waiver, implications unclear without details.
• ·Items 7.01 and 9.01 suggest additional disclosure and exhibits, content NOT_DISCLOSED.

18-12-2025

Mission Produce, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. Specific details on the affected officer, position (e.g., CEO/CFO), appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing structure; no facts on leadership impact, governance, or market signals available.

• ·Item 5.02 indicates officer-related change, but key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
• ·Items 7.01 and 9.01 suggest additional disclosure and exhibits, details NOT_DISCLOSED
• ·No quantitative data (transaction value, share count, percentages, financial metrics) extracted: all NOT_DISCLOSED

18-12-2025

Teledyne Technologies Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements/Exhibits (Item 9.01). Specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Filing appears timely per SEC requirements.

• ·Item 5.02 signals officer change event, but key position (e.g., CEO/CFO), type (appointment/resignation), and reason (e.g., retirement/performance) are NOT_DISCLOSED.
• ·No board composition impact, governance details, succession signals, or quantitative metrics (transaction value, share count, percentages) disclosed.
• ·Routine SEC disclosure; no evidence of board meeting outcomes, dividends, M&A, or compliance issues.

18-12-2025

Phibro Animal Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. This is informational with no directional bias due to lack of explicit facts.

• ·Item 5.02: Disclosure of departure, election, or appointment of directors/officers.
• ·Item 7.01: Regulation FD disclosure included.
• ·No names, positions, reasons, or financial metrics disclosed.

18-12-2025

Golden Matrix Group, Inc. filed an 8-K on December 18, 2025, disclosing an event under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements) with exhibits under Item 9.01. Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. This is a routine SEC disclosure with no explicit facts on impact.

• ·Item 5.02 filing signals officer-related change or comp arrangement, but key details (position, internal/external, reason) NOT_DISCLOSED
• ·Filed timely (within 4 business days per SEC rules)
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Sector NOT_DISCLOSED; no board composition or governance specifics provided

18-12-2025

Newton Golf Company, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, shareholder vote results under Item 5.07, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or vote outcomes are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of directors/officers, but key position, type (appointment/resignation), reason, and timing: NOT_DISCLOSED.
• ·Item 5.07 reports shareholder vote matters, but outcomes, proposals (dividends, approvals, etc.): NOT_DISCLOSED.
• ·No board composition changes, governance implications, succession details, or regulatory compliance issues explicitly stated.

18-12-2025

Parsons Corp filed an 8-K on December 18, 2025, disclosing Item 5.02 regarding departure of directors/officers, elections, appointments, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·Event and filing date: December 18, 2025
• ·All specifics (positions, appointment/resignation, reasons, financials): NOT_DISCLOSED

18-12-2025

The company filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-324753) under Item 5.02 disclosing an unspecified officer change. No details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided. Analysis limited to generic Item 5.02 event type.

• ·Item 5.02: Officer Change (Departure, Election, Appointment, or Compensatory Arrangements)
• ·Event date and filing date: December 18, 2025
• ·No company name, sector, position, or further specifics disclosed

18-12-2025

Korro Bio, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with exhibits under Item 9.01. No specific details on position affected, appointment/resignation, reasons, or quantitative data are stated in the provided filing summary. All key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 indicates officer-related change (departure, appointment, or compensatory arrangement), but specifics NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) mentioned: all NOT_DISCLOSED
• ·Routine SEC 8-K filing within required timeline; no board meeting outcomes or governance details provided

18-12-2025

Indivior PLC filed an 8-K on December 18, 2025, under Item 5.02 disclosing a departure, election, appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 filing indicates officer/director change event
• ·Filed timely: 2025-12-18 (AccNo: 0001625297-25-000076)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

ImageneBio, Inc. filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to absence of key facts from the filing.

• ·Item 5.02 filing indicates officer change but specifics (e.g., CEO/CFO, appointment/resignation, reasons) are NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Sector not specified; no board composition, governance, or market impact details available.

18-12-2025

Owens & Minor Inc/VA filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without disclosed material impacts.

• ·Item 5.02 signals officer change (departure, election, appointment, or compensatory arrangements), but key details NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional context in attachments.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) or specifics on leadership role, timing, or reasons extracted; all NOT_DISCLOSED.

18-12-2025

Drilling Tools International Corp filed an 8-K on 2025-12-18 disclosing an Item 5.02 event for officer changes (departure, election, appointment, or compensatory arrangements). No specific details on position affected, individual, reason, or quantitative data are provided in the summary. Analysis is limited; event appears routine without disclosed materiality.

• ·Item 5.02 filing indicates officer-related change but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Neutral governance signal pending full filing review

18-12-2025

Cars.com Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure facts with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director change event.
• ·Filed within SEC 8-K timeline (same day as event).
• ·No quantitative data (e.g., transaction values, shares, percentages) disclosed.

18-12-2025

Aether Holdings, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001493152-25-028360) under Item 5.02 disclosing an officer change. No specifics on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the available summary. Analysis is severely limited by lack of filing details, resulting in neutral implications.

• ·Timely SEC 8-K filing under Item 5.02 for officer change.
• ·No details on key position (e.g., CEO/CFO), type (appointment/resignation), or reasons disclosed.
• ·Sector not specified; no quantitative data (shares, values, percentages) mentioned.

18-12-2025

Pangaea Logistics Solutions Ltd. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). Specific details including officer names, positions affected, appointment/resignation status, or reasons are NOT_DISCLOSED. Analysis is limited by absence of filing content beyond item descriptions.

• ·Item 5.02 indicates officer or director change event
• ·Item 7.01 covers Regulation FD disclosure
• ·Item 9.01 lists financial statements and exhibits
• ·Filed timely on 2025-12-18 per SEC requirements; no quantitative data or specifics provided

18-12-2025

Beyond Meat, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the affected position, individual, reason, or terms are provided in the filing summary. This is a routine SEC disclosure with no quantified financial or strategic impacts stated.

• ·Item 5.02: Officer change event (departure, appointment, or compensatory arrangements)
• ·Filed: 2025-12-18, AccNo: 0001655210-25-000220
• ·No names, positions, reasons, or numerical data disclosed

18-12-2025

Intuitive Surgical Inc filed an 8-K on 2025-12-18 under Item 5.02, indicating a potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are explicitly stated in the provided filing summary. Analysis is constrained by lack of disclosed facts, resulting in neutral implications.

• ·Item 5.02 event: Generic disclosure on officer/director changes or compensatory arrangements; no names, positions (e.g., CEO/CFO), or reasons (e.g., retirement) specified.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·No board meeting outcomes, succession details, or governance impacts detailed; critical information missing.

18-12-2025

Ondas Holdings Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with other events in Item 8.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, or reasons are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates officer or director change, but key position (e.g., CEO/CFO) and nature (appointment/resignation) NOT_DISCLOSED.
• ·Items 8.01 and 9.01 suggest additional events and exhibits, details NOT_DISCLOSED.
• ·No board composition, succession, governance, or market impact details provided; analysis limited to filing structure.

18-12-2025

NOCOPI Technologies Inc/MD/ filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's name, position (e.g., CEO, CFO), nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to the event type and timing, with all other elements NOT_DISCLOSED.

• ·Item 5.02 filing signals officer or director change, but key position, appointment/resignation status, and reasons NOT_DISCLOSED.
• ·No quantitative data (transaction value, share count, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Neutral governance implications due to lack of details on internal/external hire, succession, or board impact.

18-12-2025

Ulta Beauty, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements) and exhibits under Item 9.01. No details on officer name, position, appointment/resignation, reasons, or quantitative data are provided. Analysis limited to filing metadata.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangement - specifics NOT_DISCLOSED.
• ·Timely SEC 8-K filing (within 4 business days requirement).
• ·No quantitative data (transaction values, shares, percentages, financial metrics: all NOT_DISCLOSED).

18-12-2025

Ocugen, Inc. disclosed an officer change under Item 5.02 of Form 8-K filed on 2025-12-18, but key details including position affected, appointment/resignation status, reasons, and quantitative data are NOT_DISCLOSED. No facts on governance impact, succession, or market reaction provided. Analysis limited to filing metadata.

• ·Item 5.02: Departure/Election/Appointment of Officers or Directors; Compensatory Arrangements
• ·Filing Date: 2025-12-18 (AccNo: 0001104659-25-122610)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Fidelity D & D Bancorp Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual, reason for change, or quantitative data are provided in the filing summary. This appears to be a routine disclosure with neutral implications pending further details.

• ·Item 5.02 indicates officer change, but key position (e.g., CEO, CFO), appointment/resignation status, reason, and timing are NOT_DISCLOSED
• ·Item 9.01 references financial statements/exhibits, but no details or numerical values extracted
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·No board meeting outcomes, succession details, or governance impacts specified

18-12-2025

CID Holdco, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 triggered: Indicates departure, election, or appointment of officers/directors, but specifics NOT_DISCLOSED.
• ·Item 7.01: Regulation FD disclosure filed, content NOT_DISCLOSED.
• ·Item 9.01: Financial statements/exhibits attached, details NOT_DISCLOSED.

18-12-2025

Tvardi Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001104659-25-122615), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data (e.g., transaction values, share counts) are stated in the provided summary—all marked as NOT_DISCLOSED. Analysis is limited to filing facts, with no board outcomes, succession details, or market reactions disclosed.

• ·Item 5.02 disclosure for officer change, filed within SEC 4-business-day requirement
• ·No facts on key position (CEO/CFO/COO etc.), internal/external hire, or reasons provided
• ·No quantitative data (shares, values, percentages) or governance impacts extracted—ALL NOT_DISCLOSED

18-12-2025

F&M Bank Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer/director departure, election, appointment, or compensatory arrangement
• ·Filed timely on 2025-12-18 per SEC requirements (AccNo: 0001654954-25-014119)
• ·No names, positions, reasons, or financial metrics disclosed

18-12-2025

Alight, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure of a leadership event without substantive content.

• ·Item 5.02 filing signals officer departure, election, appointment, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure - content NOT_DISCLOSED
• ·Item 9.01 lists exhibits - details NOT_DISCLOSED; no financial metrics or transaction values extracted

18-12-2025

BeOne Medicines Ltd. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are provided in the filing summary. Analysis is severely limited by absence of key facts, resulting in neutral investment implications.

• ·Item 5.02 disclosure confirms an officer or director change event.
• ·Filing date: December 18, 2025; AccNo: 0001651308-25-000151.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, reason, internal/external) disclosed.

18-12-2025

Performance Food Group Co filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 discloses officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure; content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED

18-12-2025

Vera Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the individual, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates unspecified officer or director change.
• ·No names, positions (e.g., CEO/CFO), reasons, or timing details disclosed.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

18-12-2025

Avidity Biosciences, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), other events under Item 8.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 discloses officer change; specifics NOT_DISCLOSED
• ·Filed 2025-12-18 per SEC requirements
• ·No numerical values, names, or reasons stated

18-12-2025

Cardlytics, Inc. filed an 8-K on December 18, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to filing structure; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 discloses officer change event without specifics on key position (e.g., CEO/CFO) or nature (appointment/resignation)
• ·Item 7.01 includes Regulation FD Disclosure, potentially material non-public information
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

Helix Energy Solutions Group Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without directional implications.

• ·Item 5.02: Departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements
• ·Item 7.01: Regulation FD disclosure
• ·Item 9.01: Financial statements and exhibits filed

18-12-2025

MAXIMUS, INC. filed a Form 8-K on December 18, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary. This represents a routine SEC disclosure with limited actionable information.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC requirements
• ·All specifics (position, appointment/resignation, reasons) NOT_DISCLOSED

18-12-2025

MPLX LP filed an 8-K on December 18, 2025, under Item 5.02 disclosing a change involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to header information only.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details NOT_DISCLOSED.
• ·No information on appointment/resignation, internal/external hire, reasons, or timing provided.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Marathon Petroleum Corp filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is limited to filing structure and triggered items, with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director departure, election, appointment, or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC 8-K requirements (within 4 business days)
• ·Items 8.01 and 9.01 indicate additional events and exhibits, but contents NOT_DISCLOSED

18-12-2025

Amaze Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, or reasons are provided in the filing summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates a leadership change event (officer departure, election, or appointment), but key details like position (e.g., CEO/CFO) and nature (resignation/appointment) are NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional material information.
• ·Filed timely per SEC 8-K requirements; sector NOT_DISCLOSED.

18-12-2025

PureCycle Technologies, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position, individual, reason, or quantitative data are provided in the summary. Item 9.01 references financial statements and exhibits, but content is NOT_DISCLOSED.

• ·Item 5.02 filing indicates unspecified officer change, appointment, or compensatory arrangement.
• ·No names, positions (e.g., CEO/CFO), reasons (e.g., resignation/retirement), or timing details disclosed.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Avantor, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of certain officers; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure; content NOT_DISCLOSED
• ·Item 9.01: Financial Statements and Exhibits; details NOT_DISCLOSED

18-12-2025

Sprinklr, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing items; no facts on leadership impact or market reaction available.

• ·Item 5.02: Officer change event (details NOT_DISCLOSED)
• ·Item 7.01: Regulation FD disclosure (content NOT_DISCLOSED)
• ·Item 9.01: Financial statements and exhibits filed
• ·No quantitative data (shares, values, percentages: NOT_DISCLOSED)

18-12-2025

Skillz Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer position, nature of change (appointment or resignation), reasons, or any quantitative data are NOT_DISCLOSED in the provided summary. No sector specified; analysis limited to filing metadata.

• ·Item 5.02 indicates officer or director change event, but key position, type (appointment/resignation), and reasons NOT_DISCLOSED.
• ·Item 9.01 references exhibits, but contents and any financial metrics NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

DIH HOLDING US, INC. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary.

• ·Item 5.02 indicates officer change or compensatory arrangements; specifics NOT_DISCLOSED
• ·Filed timely per SEC requirements on 2025-12-18 (AccNo: 0001493152-25-028295)
• ·Sector NOT_DISCLOSED; no quantitative data (e.g., transaction values, share counts) extracted

18-12-2025

Otter Tail Corp filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02, with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on position, appointment/resignation, reason, or quantitative data are provided in the summary. Analysis limited to filing structure; all other facts NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD disclosure, content NOT_DISCLOSED
• ·Item 9.01: Financial statements/exhibits filed, details NOT_DISCLOSED

18-12-2025

Syra Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis is limited to disclosure of the event without substantive content.

• ·Officer change event reported under SEC Item 5.02
• ·Additional Items 8.01 and 9.01 filed, details NOT_DISCLOSED
• ·No names, positions, reasons, or numerical data (e.g., shares, values) specified

18-12-2025

ENVIRI Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 indicates officer-related change, but key position (e.g., CEO, CFO) is NOT_DISCLOSED
• ·No reasons, timing, or succession details stated
• ·Item 9.01 references exhibits, but contents/content NOT_DISCLOSED; sector not specified